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Sunday, February 8, 2015 111apotency remain unexplained. We sought to determine the relevance of ICaLin
arrhythmogenic effects of one quinolone antibiotic, sparfloxacin (SPX).
Methods andResults: In thepresent study,we investigated possible involvement
of ICaL in the SPX-induced APD prolongation in neonatal rat ventricular myo-
cytes using patch clamp technique. In the presence of IKr blocker, E4031, APD
prolongation was evident perfused with sparfloxacin at 3  104 M and stimu-
lated at 2 Hz, indicating the involvement of additional channel in SPX-induced
proarrhythmic properties. The APD prolongation was associated with a slowing
of inactivation of ICaL. In contrast to SPX, four other quinolones including cipro-
floxacin, enoxacin, ofloxacin, and levofloxacin, which are not related to VT, did
not affect ICaL. Sparfloxacin increased the inactivation time constants of ICaL in a
concentration-dependent manner, resulting larger steady-state currents. Further
analysis showed that sparfloxacin reduced Ca2þ-dependent component of
steady-state inactivation. Consistent with modulation of Ca2þ-dependent inacti-
vation (CDI) by sparfloxacin, replacement of extracellular Ca2þwith Ba2þ abol-
ished sparfloxacin action on ICaL inactivation. Use-dependency wasmeasured by
applying repetitive voltage pulses at 2 Hz.We found that sparfloxacinmodulated
Ca2þ-dependent inactivation of ICaL in a use-dependent way.
Conclusion: The present findings demonstrate the role of ICaLin SPX-induced
APD prolongation. We further provide the evidence that SPX modified the
shape of ICaL by altering kinetics of Ca
2þ-dependent inactivation (APD).
This study suggests that quinolones causing delay of ICaL inactivation com-
bined with IKr block may have more adverse effects than those with purely se-
lective IKr block.
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Lethal arrhythmia is one of themajor safety concerns for developing drug candi-
date compounds, nevertheless, conventional cardiotoxicity prediction methods
like in vitro hERG/APD and in vivo QT assay cannot be eliminated the false
negative/positive problem. To overcome this problem, we have developed an
on-chip new in vitro predictive cardiotoxicity assay having a quality of clinical
screening using constructive human cardiomyocyte networks derived from hu-
man stem cells (hES-CMs) employing a spatiotemporal measurement of fluctu-
ation (short-termvariability; STV) of temporal repolarization of cells and spatial
cell-to-cell conduction, representing two origins of lethal arrhythmia. First, we
examined the electrophysiological prolongation of field potential durations
(FPDs) of human cardiomyocytes to compare the conventional in vivo QT pro-
longation and clinical results. The results showed (1) FPD prolongation has the
ability to detect QT/pro-arrhythmic risks almost similar to the conventional
in vitro APD measurements such as papillary muscle and Langendorff hearts.
However, they did not show significant improvement of the false-positive/
negative problems. Then we evaluated the new two spatiotemporal fluctuations,
and found that (2) temporal fluctuations of FPDs (STVFPD) predicted ventricular
arrhythmia risks more precisely in most of the representative compounds
including false-positive/negative compounds except for terfenadine, and that
(3) even the risk of those false-negative drugs including terfenadine was pre-
dicted by the fluctuation of spatial cell-to-cell conduction in the lined-up cardi-
omyocyte network. In conclusion, only the replacement of animal cells to human
cardiomyocytes in conventional in vitro screening is not enough to get precise
prediction, whereas, the combination of human cardiomyocytes with the new
approach of two spatiotemporal fluctuation measurements of temporal STVFPD
and spatial STVConductance gives us an potential of global precise predictive
arrhythmic cardiotoxicity as a quasi-in vivo human cell network screening
beyond conventional hERG and APD/QT assays.
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A new trend in the industry utilizes induced pluripotent stem cells (iPSCs) for
functional assays to identify cardiac pathologies and their genetic underpin-
nings (such as Long QT Syndrome (LQTS)), in addition to cardiotoxicity
profiling of pharmaceutical compounds.
The here utilized CardioExcyte 96 system is a hybrid instrument that com-
bines impedance readout (a correlate of cell contractility) with electric field po-
tential recordings of the compound signal that is generated by cellular action
potentials. These electrophysiological measurements are label-free and allowinvestigations in High Throughput format. In addition, the instrument is
capable of electrical stimulation of the cellular monolayer, while the rapid
acquisition rate of 1ms allows a more accurate description of signal features
and nuances stemming from pharmacological effects. A dedicated software
package for rapid data handling and real-time analysis is based on novel algo-
rithms that allow a comprehensive investigation of the cellular beat signal.
A broad range of cell lines was successfully validated, such as stem cell-derived
cardiomyocytes from Axiogenesis (human: Cor4U, murine: CorAt), GE
Healthcare (Cytiva), Cellectis (human, 3D-clusters: hES-CMC) and CDI
(iCell). Furthermore, the pharmacological effects of a number of reference
compounds on these cell typeswere evaluated and their phenotype correctly iden-
tified. For example, the effects of compounds like Blebbistatin, which blocks
contraction without disrupting the electric field potential can be easily identified
since it is an inhibitor of themyosin IIwhich ismainly responsible for the contrac-
tion of cardiomyocytes,while it has noeffect to the ionchannels.Other compound
classes like hERG inhibitors were validated as well and example data will be
shown. They induce typical arrhythmia since hERG ion channels are affected.
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Many drugs, both cardiac and non-cardiac, cause fatal arrhythmias. Current as-
says to evaluate arrhythmia risk based on block of the delayed rectifier Kþ cur-
rent (hERG) and QT interval prolongation are limited by poor specificity. We
hypothesize that physiological, dynamical simulations of drug effects on heart
cells will yield better algorithms to discriminate between arrhythmogenic and
safe drugs. To test this, we model drug action in cardiomyocyte models based
on drug interactionwith 3 cardiac ion channels: hERG, the L-type Ca2þ channel,
and the fast Naþ channel. For 67 distinct drugs, we measure 15 cellular physi-
ological metrics under multiple pacing conditions and in the 3 ventricular cell
types, each in 3 human ventricular cell models. Additionally, we evaluate the
influences of gender and inter-individual variability on risk by conducting sim-
ulations in both female and male models, and in a simulated population of indi-
viduals, respectively. Principal component analysis of these drug effect metrics
reveals distinct behaviors of arrhythmogenic drugs. This segregation of drugs in
principal component space facilitates their classification into arrhythmogenic
and safe categories. Our classification by this method is more sensitive and spe-
cific than the hERG block assay or, to our knowledge, any other published pre-
dictors, with an area under the receiver-operator characteristic of 0.9630.
Furthermore, because it is based on cellular physiologicalmetrics, our algorithm
can predict the arrhythmogenicity of drugswith a range of cardiacmolecular tar-
gets, beyond those of the drugs used to train the algorithm. In conclusion, we
have developed a classification algorithm using dynamical heart cell models,
suitable for cardiac safety assessments early in drug development, that outper-
forms current methods in the discrimination of arrhythmogenic and safe drugs.
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Introduction: Cardiac tissue slices, a pseudo two-dimensional organo-typic
experimental model, are an increasingly popular model to study cardiac
biophysics in-vitro. This preparation benefits from moderate complexity, native
cell-type presence, and locally preserved cell-cell connections. We used optical
mapping of tissue slices to monitor transmembrane potential (Vm) and intracel-
lularCa2þ concentration to study the effects of stretch onactionpotential duration
(APD) and calcium transient (CaT) dynamics with a relatively high spatio-
temporal resolution, to explore mechanisms of stretch-induced arrhythmias.
Methods: Langendorff perfused rabbit hearts were loaded with dyes for Vm
(di-4-ANBDQPQ) and CaT (Rhod-2-AM). Thereafter, 350 mm tissue slices
were vibratome-cut from left and right ventricular free wall in an
epicardium-tangential plane. Slices were attached at their ends to a manual
stretcher and optically mapped using an EMCCD camera with LED excitation
light sources. Slices were field stimulated at 2Hz, and Vm and CaT were
measured before, during (up to 50min) and after application of stretch.
Results: Cardiac tissue slices (n¼9), exposed to stretch (by 4-12%) showed an
initial shortening in both APD and CaT duration (APD80 and APD50 reduced
112a Sunday, February 8, 2015by 10.7% and 11.4%, respectively; CaT80 and CaT50 reduced by 6% and
5.3%, respectively). During maintained stretch, a gradual re-lengthening of
APD and CaT duration was observed. After release of stretch, APD and CaT
duration reverted to shorter values.
Conclusion: Living cardiac tissue slices offer a promising experimental model
for the study of cardiac mechano-electric coupling. The methodology described
can be refined (e.g. using a computer-controlled motorised stage to synchronise
electrical and mechanical events, and by use of fiducial markers to track local
tissue deformation rather than only input strain levels) and extended (e.g.
exploring effects of stretch directionality, relative to prevailing cell orientation
in a slice).
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Sympathetic nerve in heart is essential in cardiac physiology and diseases,
because it releases catecholamines to regulate cardiac cells including ven-
tricular myocytes, atrial myocytes and vas through GPCRs. With a modified
glass-insulated micro carbon fiber electrode (pegCFE), we record stimulus (de-
polarization or hypoxia)-signals via either amperometric current (Iamp) or fast
cyclic voltammetry from the nerve terminals in rodent hearts, by a method
termed cardiac Slice of ElectroChemistry (cSEC). We found that, (1) cSEC
signal Iamp is dependent on CFE-voltage and extracellular Ca
2þ; (2) pharmaco-
logically, Iamp is increased 40% by Yohimbine, and decreased 60% by reser-
pine; (3) electronic microscope detected dese core vesicles, tyrosine
hydroxylase (TH) immunostaining and TH-GFP transgenic mice showed
massive TH-signal in whole heart; (4) as determined by in-situ FCV, as well
as microdialysis-based HPLC, NE and/or DHPG (a NE metabolic substance)
were responsible for cSEC signals. These evidences establish that the evoked
cSEC signals represent catecholamine releases from sympathetic nerves in
heart slices. Using cSEC we discovered that hypoxia-reperfusion triggered
dual spikes of catecholamine release at pH 7.4: first peak at 10s following
hypoxia perfusion, second peak at 10s following normoxia perfusion. Finally,
catecholamine release were reduced by 75% in ventricle slices from syt7(Ca2þ
sensor)-KO versus WT mice, indicating cSEC may serve phenotyping of any
sympathetic defects in cardiac disease animal models.
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Cardiomyocytes derived from human induced pluripotent stem cells (hIPSC-
CMs) provide a promising platform for understanding human cardiac pathol-
ogy and physiology. HIPSC-CMs differentiate into a mixed population of cells
composed of ventricular, atrial, and nodal cell types; cellular phenotype is
generally distinguished by morphology of the action potential (APs). However,
in hIPSC-CMs a very small inward rectifying potassium channel (IK1) relative
to native cardiac cells causes a depolarized membrane potential which contrib-
utes to inconsistent AP properties and misidentification of cellular phenotype.
We used Electronic expression of IK1 via dynamic clamp to restore the AP and
resting membrane potential back to a physiological levels. This allowed for
improved discrimination of atrial and ventricular cells based on APmorphology.
Using standard patch clamp techniques,we compared the inward sodiumcurrents
(INa) of cells with atrial and ventricular AP morphologies. INa current densities
in cells with atrial like APs were larger than ventricular-like APs (at30 mV, in
pA/pF:71.225 6.96 (n¼5) vs.46.2555.03 (n¼14), p< 0.05). Analysis of
steady-state inactivation parameters of INa showed that cells with an atrial like
AP had a more negative steady-state inactivation (V1/2: 81.845 2.75 (n¼5)
vs. 74.72 50.8 (n¼14), p<0.05). Cells with atrial APs had a larger Kv1.5-
like component at þ50 mV than ventricular APs (in pA/pF: 3.715 0.55 (n¼5)
vs 1.005 0.10 (n¼16),P<0.05) but similar peak currents: (6.895 0.50 (n¼5)
vs. 6.585 0 .67 (n¼14),P¼N.S). IK1 current density was more than 3x smaller
in cells with atrial-like APs at 120 mV (in pA/pF: 0.71 5 0.08 (n¼5) vs.3.45 5 0.61 (n¼14), p<0.05). These data suggest that differential AP
morphology in hIPSC-CMhas a similar electrophysiological basis to native cells.
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Cardiac myocytes derived from human induced pluripotent stem cells (hiPSC-
CMs) are a useful and renewable human myocyte model. Despite their promise,
these cells haveunexplored limitationswhen applied to action potential (AP) anal-
ysis. APs occur spontaneously and are associated with variability due to a small/
missing inwardly rectifying potassium channel (IK1).We usedwhole cell voltage
clampwith dynamic clamp toexpress IK1,which significantly improved the phys-
iological behavior of the AP and electrical profile of hiPSC-CMs.
hiPSC-CMs have a negligible peak IK1 at 120 mV (0.81 5 0.4 pA/pF)
which results in depolarized resting membrane potentials (RMP) (60.0 5
1.7 mV, n¼17). ‘‘Electronic transfection’’ of IK1 into hiPSC-CMs results in re-
establishing a physiological RMP (84.0 5 0.2 mV), increases the maximal
upstroke velocity (from 82.15 2.4 to 161.65 11.5 mV/ms), reduces AP dura-
tion, and increases the rate of repolarization (from 0.35 5 0.03 to 1.1 5
0.1 mV/ms, n¼17). Despite a detectable transient outward potassium current
in hiPSC-CMs, ‘‘spike and dome’’ morphology is generally absent in spontane-
ously active cells; addition of electronic IK1 restored this morphology in 12 out
of 17 ventricular cells. It also restored the relationship between maximum up-
stroke velocity and sodium current density. The stabilized membrane potential
allowed systematic measurement of dynamic parameters. The rate dependence
of the AP duration was measured in at different pacing rates from 4000 to
500 ms in 12 electronic IK1 expressing hiPSC-CMs and showed a classical
monotonic restitution curve, with AP increasing with increased cycle length.
By removing sodium channel inactivation, electronic expression of IK1 im-
proves hiPSC-CMs utility in assess mechanisms involving sodium channels
and phase 1 repolarization such as LQT3 and Brugada Syndrome.
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Atrial myocytes are subjected to fluid shear force (FSF) during each contraction
and relaxation. Ionic currents regulated by shear force and their molecular integ-
rity in cardiac myocytes have not been well-understood. We examined whether
FSF activates specific current in atrial myocytes and underlyingmechanisms for
FSF-sensitive ionic current using whole-cell patch-clamp technique. A FSF of
~16 dyne/cm2 was applied to entire single atrial myocyte using automated
micro-puffing apparatus. A FSF-sensitive current (IFSF) was detected in lowly
Ca2þ-buffered (0.5mMEGTA) atrialmyocytes, but not in highlyCa2þ-buffered
(R4 mM EGTA or 10 mM BAPTA) myocytes. The IFSF showed an outward
rectification with a reversal potential of about -6 mV. The IFSF was inhibited
by high concentrations (20-50 mM) of ryanodine and by replacement of external
and internal cation with impermeant NMDGþ, suggesting that IFSF is a Ca
2þ
release-dependent cation current. Application of either transient receptor poten-
tial melastatin subfamily 4 (TRPM4) inhibitor 9-phenanthrol or TRPM4-
specific antibodies removed most of inward IFSF and ~80% of outward IFSF.
However, stretch-activated cation channel blocker GsMTx-4 did not affect
IFSF. Interestingly, IFSF was strongly inhibited by inositol 1,4,5-trisphosphate re-
ceptor (IP3R) blockers, 2-APB (2 mM) or xestospongin C. In addition, in atrial
myocytes isolated from type 2 IP3R (IP3R2) knock-out mouse, IFSF was not de-
tected, although 9-phenanthrol-sensitive IFSF was recorded in wild-type myo-
cytes. Co-immunostaining of TRPM4 and IP3R2 in rat atrial myocytes
revealed peripheral localization of these proteins with some co-localizations.
These results suggest that fluid shear stimuli may activate TRPM4 channels in
atrial myocytes via Ca2þ releases triggered by the activation of nearby IP3R2.
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STIM1 is a Sarcoplasmic Reticulum (SR)membrane resident protein implicated
in sensing and maintaining SR Ca2þ levels. The role of STIM1 in the regulation
